Full Text View
Tabular View
No Study Results Posted
Related Studies
Genetics of Ankylosing Spondylitis
This study has been completed.
First Received: April 15, 2004   Last Updated: February 19, 2008   History of Changes
Sponsored by: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Information provided by: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
ClinicalTrials.gov Identifier: NCT00081562
  Purpose

Ankylosing spondylitis (AS) is a chronic inflammatory disease that affects the joints between the vertebrae of the spine and the joints between the spine and the pelvis. The purpose of this study is to collect information and blood samples from patients with AS and their relatives for use in genetic studies.


Condition
Spondylitis
Ankylosing Spondylitis

Study Type: Observational
Official Title: Family Studies of the Genetics of Ankylosing Spondylitis

Resource links provided by NLM:


Further study details as provided by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS):

Estimated Enrollment: 1600
Study Start Date: September 1999
Study Completion Date: December 2006
Primary Completion Date: December 2006 (Final data collection date for primary outcome measure)
Detailed Description:

AS is a chronic inflammatory disease that eventually causes the affected vertebrae to fuse or grow together. The cause of AS is unknown, but genetic factors seem to play a role. Risk factors include a family history of ankylosing spondylitis and male gender.

This study will collect patient information and blood samples from affected patients (and when available, both parents of the affected patients) of 400 families with children fulfillling the modified New York criteria for AS. Diagnosis of AS will be verified by patient questionnaire, medical record review, and pelvic radiographs.

Information from these patients will be used to search the human genome for disease-associated loci and/or genes.

This study will also utilize contributions of investigators who have conducted recent clinical or genetic research in AS at 10 academic medical centers throughout North America (the North American Spondylitis Consortium, or NASC).

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Meet modified New York criteria for ankylosing spondylitis (AS)
  • AS as confirmed by X-rays of sacroiliac joints (between the pelvis and spine)
  • At least two siblings in family with AS
  • Parents of the participants with AS have the option of also being enrolled
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00081562

Locations
United States, California
Cedars-Sinai Medical Center
Los Angeles, California, United States, 90048
United States, Texas
University of Texas - Health Science Center at Houston
Houston, Texas, United States, 77030
Sponsors and Collaborators
Investigators
Principal Investigator: John D. Reveille, MD The University of Texas Health Science Center, Houston
  More Information

Additional Information:
Publications:
Study ID Numbers: NIAMS-098, 5R01 AR046208-05, NASC
Study First Received: April 15, 2004
Last Updated: February 19, 2008
ClinicalTrials.gov Identifier: NCT00081562     History of Changes
Health Authority: United States: Federal Government

Study placed in the following topic categories:
Spinal Diseases
Musculoskeletal Diseases
Spondylarthropathy
Arthritis
Joint Diseases
Spondylitis, Ankylosing
Spondylarthritis
Bone Diseases
Spondylitis
Ankylosis
Spondylarthropathies

Additional relevant MeSH terms:
Spinal Diseases
Musculoskeletal Diseases
Arthritis
Joint Diseases
Spondylitis, Ankylosing
Infection
Spondylarthritis
Bone Diseases
Spondylitis
Ankylosis
Spondylarthropathies
Bone Diseases, Infectious

ClinicalTrials.gov processed this record on September 10, 2009